By binding to GLP-1 receptors in the brain, pancreas, and gastrointestinal tract, Wegovy produces several therapeutic effects: it enhances insulin secretion in a glucose-dependent manner, suppresses glucagon release, slows gastric emptying, and reduces appetite through central nervous system pathways that regulate satiety
Wait for 3 months after receiving a blood transfusion from another person
The STEP trials are testing semaglutide at the higher dose of 2.4 mg/week (as compared to 1.0 mg/week for the original diabetes indication), specifically for promoting weight loss, regardless of the presence of type 2 diabetes
T50 provides more doses per vial, making it more convenient for long-term treatment
How to take each dose Take once every morning on an empty stomach Swallow whole with no more than 100ml of water more than this reduces absorption Do not chew, split, or dissolve the tablet Wait at least 30 minutes before eating, drinking (anything other than water), or taking other medicines Can I Switch From the Wegovy Injection to the Tablet
Peptides 32, 22652273